InvestorsHub Logo

Johnny_C

03/25/20 1:01 PM

#49067 RE: BAE44 #49066

Of course they don't, especially when it comes to safety data.

1. Safety

2. Efficacy

I would suggest everyone read the FDA's approval of another CBD product and the general position they take on CBD in general.

If and when (just for loan) the trails prove the gum works this is a potential multi-billion dollar a yr biz. That is for starters.

Unlike most drug trials that have to go through animal trials and then 6 legs of phase 1-3, what would happen if hundreds of potential patients have decreased nausea in phase 1...

Just say'n Do you think the FDA has stopped trials of a drug with no negative safety profile early if the efficacy was overwhelmingly positive.

We will not know until we get to that point